Search
for
Sort by
Research 901–930 of 1000+
- Topical photochemotherapy for alopecia areata
- Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Sulfasalazine for alopecia areata
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Role of platelet-rich plasma in chronic alopecia areata: Our centre experience
- Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: A double-blind randomized controlled study
- Dietary soy oil content and soy‐derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice
- Traction alopecia: the root of the problem
- The role of lymphocytes in the development and treatment of alopecia areata
- Alopecia areata incognita: A Hypothesis
- Treatment of severe alopecia areata with intralesional steroid injections.
- Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice
- Multi-layered environmental regulation on the homeostasis of stem cells: The saga of hair growth and alopecia
- Acute Diffuse and Total Alopecia of the Female Scalp
- Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata
- The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results
- Review of quality of life studies in women with alopecia
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Platelet-rich plasma as a potential treatment for noncicatricial alopecias
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Targeted Expression of Human Vitamin D Receptor in the Skin Promotes the Initiation of the Postnatal Hair Follicle Cycle and Rescues the Alopecia in Vitamin D Receptor Null Mice
- Local Injection of Steroids and Hair Regrowth in Alopecias
- Alopecia Areata: Current Treatments and New Directions
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity